Surface antigens analysis reveals significant expression of candidate targets for immunotherapy in adult acute lymphoid leukemia

Leuk Lymphoma. 2011 Feb;52(2):325-7. doi: 10.3109/10428194.2010.529206. Epub 2010 Nov 15.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antibodies, Monoclonal / therapeutic use*
  • Antigens, CD / immunology
  • Antigens, CD / metabolism
  • Antigens, CD19 / immunology
  • Antigens, CD19 / metabolism
  • Antigens, CD20 / immunology
  • Antigens, CD20 / metabolism
  • Antigens, Differentiation, Myelomonocytic / immunology
  • Antigens, Differentiation, Myelomonocytic / metabolism
  • Antigens, Neoplasm / immunology*
  • Antigens, Neoplasm / metabolism
  • Antigens, Surface / immunology*
  • CD52 Antigen
  • Flow Cytometry
  • Glycoproteins / immunology
  • Glycoproteins / metabolism
  • Humans
  • Immunophenotyping
  • Immunotherapy*
  • Middle Aged
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / immunology*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / metabolism
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
  • Prognosis
  • Sialic Acid Binding Ig-like Lectin 2 / immunology
  • Sialic Acid Binding Ig-like Lectin 2 / metabolism
  • Sialic Acid Binding Ig-like Lectin 3
  • Young Adult

Substances

  • Antibodies, Monoclonal
  • Antigens, CD
  • Antigens, CD19
  • Antigens, CD20
  • Antigens, Differentiation, Myelomonocytic
  • Antigens, Neoplasm
  • Antigens, Surface
  • CD33 protein, human
  • CD52 Antigen
  • CD52 protein, human
  • Glycoproteins
  • Sialic Acid Binding Ig-like Lectin 2
  • Sialic Acid Binding Ig-like Lectin 3